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Abstract 14 
Injectable veterinary medicinal products (VMPs) are widely used in cattle in the UK, and in particular 15 
vaccines are often used on large numbers of animals in the herd. The formation of injection site 16 
lesions (ISLs) is a risk when using injectable products, and has potential consequences for meat 17 
quality, animal welfare and beef industry income. This study used carcase observation in four 18 
abattoirs in England to determine ISL prevalence in beef cattle. Additionally a questionnaire survey 19 
was used to investigate  vaccination technique amongst UK beef farmers. The ISL prevalence was 20 
4.1% (95% confidence interval 3.4-4.9%). A potential difference between sites being used for 21 
vaccination and the distribution of ISLs on carcasses suggested that factors other than vaccination 22 
were contributing to ISL incidence. Questionnaire responses highlighted deficits in good vaccination 23 
practices such as using the recommended site of injection and needle hygiene. The role of the 24 
veterinarian in knowledge transfer is crucial in providing practical injection advice when prescribing 25 
vaccines and other VMPs. This study identified factors to address when aiming to reduce ISL 26 
formation in UK beef animals.  27 
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Introduction 33 
A wide range of injectable veterinary medicinal products (VMPs) are available for use in beef cattle 34 
in the UK, including vaccines, antibiotics, anti-inflammatory drugs, mineral supplements and 35 
reproductive hormones. Large proportions of these are intended for intramuscular injection and are 36 
often administered by farmers. Injections can cause trauma to tissues resulting in an inflammatory 37 
response and potential injection site lesions (ISLs) such as cysts, discolouration, nodules or abscesses 38 
and subsequent scar tissue (Dexter and others 1994, Van Donkersgoed and others 1999, Roeber and 39 
others 2001). 40 
Antibiotics, reproductive hormones and other VMPs are predominantly used on an individual animal 41 
basis in beef cattle in the UK, whereas vaccines are usually administered to the whole herd or a 42 
managed group within the herd, for example, newly introduced animals or young stock. Seventy-43 
nine percent of UK beef farmers use vaccines (Cresswell and others, 2014) and it can therefore be 44 
assumed that the majority of beef animals passing through abattoirs have been vaccinated during 45 
their lives. With the current emphasis on preventative medicine and reduced antibiotic usage in 46 
animal production, the use of vaccination is of increasing significance, and it may be considered 47 
important to be aware of the associated risks. 48 
Although damage to meat is possible through mechanisms other than injection (e.g. injury), ISLs are 49 
of concern due to the loss of quality, value and palatability of meat (George and others 1997). The 50 
widespread use of injectable VMPs indicates that ISLs could be a significant reason for carcase 51 
trimming. It is hypothesised that the VMP administered, and the subsequent antigenic response, 52 
could impact the taste and texture characteristics of the surrounding meat, even if the lesion is 53 
trimmed (Van Donkersgoed and others 1997). Injection site lesions in meat could also have 54 
implications for human health through toxic residues at injection sites (Reeves, 2007). In addition, 55 
compromises to animal welfare through trauma, inflammation and infection should be avoided 56 
where possible. Economic loss to the farmer, abattoir and wider industry can result from trimming of 57 
lesions from the carcase. This results in lower deadweight payments to the farmer, and also means 58 
that meat from valuable cuts, such as the rump area, may have to be discarded. Data from the Food 59 
Standards Agency in the UK (FSA) indicated the incidence of abscesses in beef carcasses to be 60 
approximately 6% in 2014 (FSA, 2014); this figure is including intramuscular and hepatic abscesses. 61 
In the USA there was a reduction in injection site lesion incidence in beef top sirloin butts from 11% 62 
in 1995 to 2% in 2000 following national efforts to educate farmers on the losses associated with 63 
ISLs. This was achieved through the National Cattlemen’s Beef Association instigating Beef Quality 64 
Assurance training programs, and publication of guidelines (Appendix 1), with subsequent audits and 65 
assessment against these guidelines (Roeber and others 2001). Roeber (2001) estimated that a 9 66 
percentage point reduction in ISLs across a five-year period generated savings of approximately 67 
US$76 M to the USA meat industry. Although no similar data are available for the UK this suggests 68 
that ISLs represent a considerable potential economic loss for the industry. 69 
It is often recommended to inject cattle in the musculature of the neck rather than the rump muscle, 70 
as the neck contains meat of lower value (EBLEX, 2013). It has been hypothesised that fewer ISLs 71 
occur if injected in the neck due to injected products being restricted to more localised areas by the 72 
nature of the anatomy of the fascial planes, and due to the extensive lymphatic supply resulting in 73 
rapid absorption (Glock and others 1995).  74 
In terms of ISLs, intramuscular (IM) injection is of the most concern as the muscle tissue is used for 75 
human consumption. However, subcutaneous (SC) vaccines can also lead to muscle damage as 76 
described by Van Donkersgoed and others (1999) with respect to clostridial vaccines. Guidelines for 77 
administration of VMPs in cattle are provided on datasheets that accompany all licenced VMPs. 78 
Previous research showed that compliance with datasheet instructions could be improved; only 33% 79 
of UK cattle farmers who participated in the study referred to the datasheet before administering 80 
vaccines (Cresswell and others 2014). Many of the injectable product datasheets recommend using 81 
aseptic techniques when injecting cattle, although in practice this is rarely carried out, especially 82 
when large numbers of animals are injected, such as during herd vaccination (Cresswell and others 83 
2014). The consequences of not following datasheet instructions have not been well documented in 84 
farm animals, but human studies indicate that practices such as poor needle hygiene increase the 85 
chance of infection and abscessation (Murphy and others 2001).  86 
The aim of this study was to investigate the prevalence of ISLs in UK beef cattle, and to investigate if, 87 
and how, injectable vaccines may contribute to ISLs. 88 
 89 
Materials and Methods 90 
Abattoir 91 
Four abattoirs were visited between April 2009 and April 2010. The abattoirs selected for the study 92 
were a convenience sample, based on throughput of beef cattle only (excluding dairy culls) and their 93 
geographical location in England (two in Cumbria, one in Gloucestershire, and one in Somerset). 94 
Letters were sent to abattoirs prior to the visit to explain the purpose of the study. Once 95 
participation was agreed, the researchers met with the FSA staff (official veterinarian and meat 96 
inspectors) and slaughterhouse staff to confirm their past experience in identifying lesions.  97 
Two control points were designated at each abattoir. These were set up at the end of the dressing 98 
line immediately after slaughter and in the deboning and butchery area, so that the researchers 99 
could observe the routine inspection process without disrupting the normal throughput of carcasses. 100 
Inspections were carried out on two consecutive days at each abattoir, for the full duration of the 101 
working day. All carcasses on these two days were examined for lesions. Carcasses were inspected 102 
visually by FSA and slaughterhouse staff at both control points. Lesions or abnormal tissue were 103 
trimmed from the carcase. It was assumed that injection was the most likely cause of these lesions in 104 
these commonly used injection sites. The tissue was labelled with date and kill number and a gross 105 
morphological description was recorded. The anatomical site of each lesion was recorded and 106 
subsequently categorised as per Figure 1. The ISL samples were stored on ice and taken to the 107 
laboratory where they were incised to identify the underlying structures. Lesion samples were 108 
photographed and the greatest diameter of each lesion was recorded.  109 
Questionnaire 110 
A questionnaire was developed and distributed in paper format and online to cattle farmers in the 111 
UK between September and November 2011 using a convenience sample. The questionnaire 112 
contained 23 questions about cattle vaccine uptake, and collected data on how the vaccines were 113 
stored and administered. Results not presented in this study are published in Cresswell and others 114 
(2014), where a detailed description of the methods is provided. 115 
Respondents were asked what vaccines they used, to identify which vaccine they were most familiar 116 
with and answer questions about route of administration, needle usage and instructions regarding 117 
that particular vaccine. Respondents were asked to identify the site at which they vaccinate by 118 
marking an ‘x’ on an image of a cow; the site was subsequently categorised as per Figure 1.  For this 119 
study, results from the beef respondents only were used. 120 
Where applicable, vaccine use was categorised as ‘correct’ or ‘incorrect’ (e.g. route and site of 121 
administration) according to the information provided on the vaccine datasheet (National Office of 122 
Animal Health, 2010). ‘Datasheet’ in this study refers to the information sheet provided with the 123 
vaccine, which for most manufacturers in the UK is also published by the National Office of Animal 124 
Health (NOAH, 2010). This is an abbreviated form of the Summary of Product Characteristics (SPC), 125 
which is the legally approved document for all licenced VMPs available through the Veterinary 126 
Medicines Directorate (http://www.vmd.defra.gov.uk/productinformationdatabase/). 127 
Data analysis 128 
Questionnaire and abattoir data were analysed using Microsoft Excel 2010 (Microsoft, Redmond, 129 
USA). A histogram was used to assess the distribution of the size of the lesions to subsequently 130 
categorise these as 'small' (0.1-7.9 cm), 'medium' (8-15.9 cm) or 'large' (16-23cm).  131 
Statistical analysis was carried out in R (R Core Team, 2013). Fisher’s exact test was used to test 132 
associations between size and site of lesions. Pearson’s Chi-squared test with Yates’ continuity 133 
correction was used to test associations between site of vaccination and site of lesions.  A P-value 134 
≤0.05 was considered significant. 135 
The study received ethical approval from the School of Veterinary Medicine and Science Ethics 136 
Committee, The University of Nottingham.  137 
Results 138 
Abattoir  139 
Injection site lesion prevalence  140 
2853 beef carcasses were examined and 117 lesions were recorded (4.1%, 95% confidence interval 141 
3.4%-4.9%).  142 
Site and size of lesions 143 
Information which described the location on the carcase was available for 93 lesions. This 144 
information was not recorded for the remaining 24 lesions as some samples were provided from 145 
butchery inspection where the precise carcase location was no longer readily apparent. Out of these, 146 
47% (n=44/93) were located in the rump and 42% (n=39/93) were located in the neck. The 147 
remaining 11% (n=10/93) were located in other sites such as the ribs and flank. 148 
Data on the size of the lesion were available for 104 cases. The measured maximum diameter of 149 
lesions ranged from 1 to 23 cm. Twenty-three percent were described as small (diameter of 1-150 
7.9cm), 67% as medium (8-15.9cm) and 10% large (16-23cm). 151 
There appeared to be larger lesions in the rump compared with the neck, however this was not 152 
statistically significant (p=0.2) (Table 1). Due to information being unavailable from some of the 153 
observed lesions, it was only possible to compare lesion size with lesion site for 81 lesions.   154 
Description of lesions  155 
A variety of lesion types were identified. Gross morphological descriptions were identified for 76 of 156 
the lesions. Many descriptors identified the lesions as being chronic in nature or being the residual 157 
and resolving remnants of previous lesions rather than an active infection, e.g. steatosis, scar tissue 158 
and fibrosis. Some lesions were specifically described as abscess or pus, suggesting current infection, 159 
and less commonly, lesions were identified as cysts, nodules, haemorrhages or melanistic 160 
(pigmented).  161 
Questionnaire 162 
Ninety-two questionnaire respondents classified themselves as beef farmers. Different numbers of 163 
respondents were excluded from data analysis of each question due to  incomplete responses, for 164 
example not identifying a specific vaccine at the start of the questionnaire.  165 
Route and site of vaccine administration  166 
When asked ‘Which route of administration did you use for this vaccine?’, 56% (n=40/72) of 167 
respondents used the subcutaneous route and 40% (n=29/72) of respondents used the 168 
intramuscular route. For some respondents it was not possible to assess whether the route of 169 
administration used was in accordance with the datasheet recommendations because they had not 170 
clearly specified which vaccine they were using, or indicated more than one route of injection; these 171 
responses were excluded from further analysis. For vaccines to be administered subcutaneously, the 172 
correct route of administration was chosen by 86% (n=26/30) of respondents. For intramuscular 173 
vaccines, the correct route was chosen by 79% (n=19/24) of respondents.   174 
When asked to indicate the site of injection, significantly more respondents injected in the neck 175 
(p=0.002); 60% of respondents injected in the neck (n=40/66) and 33% of respondents injected in 176 
the rump (n=22/66) (Figure 1). Thirty-seven responses were excluded from further analysis as the 177 
datasheet for the vaccine they were using did not recommend administration in a specific site on the 178 
animal, or the respondent had indicated more than one site. Seventy-two percent (n=21/29) of 179 
respondents administered vaccines in the correct site. 180 
No significant difference (p=0.22) was detected in distribution between site of vaccine 181 
administration (60% in neck, 33% in rump) and site of lesions observed at the abattoir (42% in neck, 182 
47% in rump)..  183 
There were 60 respondents who provided answers to both questions regarding route and site of 184 
administration. The majority of these respondents vaccinated cattle subcutaneously in the neck 185 
(45%, n=27), or intramuscularly in the rump (28%, n=17). Nine respondents were vaccinating 186 
intramuscularly in the neck, and two were vaccinating subcutaneously in the rump. The five 187 
remaining respondents vaccinated elsewhere on the animal, or indicated to use a non-injectable 188 
vaccine. 189 
Needle usage when vaccinating beef cattle 190 
When asked ‘When administering this vaccine by injection, which of the following apply on your 191 
farm?’ 43% of respondents started each vaccination session with a new needle or changed needles 192 
when they became broken or blunt (Table 2).   193 
Instructions used by farmers when vaccinating beef cattle 194 
When asked ‘What instructions did you follow when administering this vaccine?’ 20% of 195 
respondents indicated they did what they had done previously and did not need instructions (Table 196 
3). 197 
Discussion 198 
The prevalence of ISLs (4.1%) detected in the abattoir was lower than the FSA national average of 199 
approximately 6% in 2014. This is to be expected as the FSA data included hepatic abscesses which 200 
would not be directly caused by intramuscular or subcutaneous injection. This is higher than the 201 
2.1% ISL incidence reported in the USA in 2000 (Roeber and others 2001) and represents a significant 202 
potential financial loss to the beef industry and a welfare concern through discomfort and pain in 203 
the affected animals.  204 
In 2014, 2,669,000 cattle were slaughtered in the UK (AHDB, 2015). If the 4.1% incidence of ISLs 205 
were an unbiased, random representation of animals for the UK it could be extrapolated that 206 
between 90,700 and 130,000 beef cattle annually could have ISLs. Although the study sample was  a 207 
small convenience sample based in four abattoirs, there are no confounding factors to suggest that 208 
the prevalence, site and size of ISLs differ from other abattoirs in the UK. Moreover, the ISL 209 
prevalence in this study is likely an underestimate of the true prevalence, as lesions could have been 210 
missed during inspection as mainly superficial ISLs are observed; Roeber and others (2001) report 211 
that ISLs are seldom detected at packing plants because damage is concealed within the muscles and 212 
subcutaneous fat.  213 
The proportion of ISLs in the carcasses were similar between the neck (47%) and rump (42%) area, 214 
whereas the sites at which respondents were vaccinating differed with 60% vaccinating in the neck 215 
and 33% vaccinating in the rump (p=0.002). Although there was no statistically significant difference 216 
in neck-rump proportions between lesions and vaccination sites (p=0.22), investigating a larger 217 
sample size may demonstrate significance. Therefore the relevance of factors other than vaccination 218 
may be responsible for the formation of ISLs. The two parts of this study were carried out during 219 
different time periods (abattoir data from 2009-2010 and questionnaire data during 2011), in two 220 
different target populations. However, it is not expected that producer’s injection practices and ISL 221 
prevalence would have varied significantly during this time. 222 
Large injected volumes of VMPs are thought to produce a greater number of, and larger abscesses 223 
and granulation tissue than smaller injected volumes (Van Donkersgoed and others, 1999). It could 224 
therefore be hypothesised that antibiotics and anti-inflammatories, which tend to be injected in 225 
higher volumes in cattle, would be more likely to cause ISLs than vaccines which are injected in 226 
relatively small (2-5ml) volumes. Reproductive hormones are also administered in 2-5ml doses but 227 
have been demonstrated to be damaging to meat quality in a study using creatine kinase levels as a 228 
marker of muscle damage following injection (Fajt and others 2014).  229 
The type and extent of reaction appears to vary between different injectable VMPs and product type 230 
may be more significant than product volume – for example, clostridial vaccines are noted for their 231 
irritability, readily producing localised damage (Van Donkersgoed and others 1999) with up to 17% 232 
forming abscesses and reactions that persist for 10 week or more (NOAH, 2010), whereas the 233 
antimicrobial tilmicosin, administered subcutaneously and in large volumes, did not appear to cause 234 
ISLs (Van Donkersgoed and others 2000). It has been proposed that modified live vaccines produce 235 
fewer ISLs than killed vaccines, due to the oil-based adjuvants used in killed vaccines (Van 236 
Donkersgoed and others 1999, McFarlane and others 1996), although other studies found no 237 
difference between ISL incidence using killed or modified live vaccines (Van Donkersgoed and others 238 
2000).  239 
VMPs are frequently administered in the rump as this provides a large area that is convenient to 240 
inject, often more so than the neck which can be restricted by handling facilities. The economic 241 
impact of ISLs may vary depending on which area of the rump is used for injection, i.e. dorsal gluteal 242 
muscle vs caudal fold; this study provides limited detail with regards to the precise site indicated by 243 
the respondents. Considering the finding of the rump to be such a common injection site, future 244 
research should investigate techniques in more detail to accurately assess the impact of losses when 245 
using the rump as injection site. 246 
Dexter and others (1994) found that 80-90% of all ISLs were older lesions which is supported by the 247 
findings of this study; many of the descriptions suggested that an ISL had occurred prior to slaughter 248 
but the active reaction had since resolved. George and others (1995) demonstrated that the time 249 
elapsed since injection is not necessarily proportional to the presence of ISLs, and that ISLs were 250 
present up to 12 months after (clostridial) vaccination had been carried out.  This demonstrates the 251 
risk of ISLs when injecting cattle at any time point before slaughter.  252 
This study did not find a relationship between vaccination use and ISLs in beef cattle; however, the 253 
findings were limited by the number of questionnaire respondents and the fact that the abattoir 254 
data did not originate from cattle produced by questionnaire respondents. However, this initial data 255 
highlights the need to improve our understanding of the causes of ISLs. Prospective longitudinal 256 
studies identifying which injectable VMPs were administered when, and subsequent carcase 257 
inspection would be required to investigate the long-term implications of injecting specific VMPs. 258 
Such a study could assess more accurately the relative impact of the widespread use of vaccines in 259 
comparison with other VMPs. Whilst this could provide valuable information for veterinarians and 260 
farmers on how to avoid ISLs in beef cattle, accurate and systematic data recording on farm is 261 
challenging, which will affect the quality of data available for analysis (Velasova and others 2015). 262 
The practical and logistical difficulties involved in conducting such a study have so far been 263 
prohibitive to the carrying out of such a project. This retrospective study therefore provides an 264 
important indication of the current ISL prevalence and potential risk factors in UK beef cattle and 265 
supports the need for further investigation into this area. Although selecting VMPs based on their 266 
product characteristics (including tendency to form ISLs) is relevant, areas related to compliance, 267 
such as poor needle usage and site of administration are also within the control of the veterinarian 268 
and farmer. A cost-benefit analysis can be made when administering a vaccine; the risk of ISL 269 
formation must be balanced with the potential to control disease, which may include financial, 270 
welfare and public health benefits, including reduced antimicrobial usage. Vaccination therefore 271 
remains important for the UK beef industry and should not be disregarded because of the risk of ISL 272 
formation. Instead, efforts should be focused on reducing risk factors, such as addressing why only 273 
72% of UK beef farmers are using the correct route of administration, or fewer than half of 274 
respondents are only changing the needle when broken or blunt.  275 
Using broken or blunt needles increases the chance of causing tissue trauma, resulting in a greater 276 
inflammatory reaction (Xie and others 2014). Not changing needles or not employing aseptic 277 
techniques increases the chance of transferring pathogens between animals and ISL formation 278 
(Niskanen and Lindberg, 2003), which is particularly relevant where vaccination is being used for a 279 
whole herd. Fewer than 50% of respondents were following datasheet recommendations with 280 
regard to needle usage and only 40% consulted the datasheet during a vaccination session. This 281 
corroborates a study on BVD vaccination by Meadows (2010) where one third of UK farmers never 282 
referred to the datasheet and where overall compliance with datasheet recommendations was poor. 283 
Information on vaccine bottles that only provide brief information, were consulted by 56% of 284 
respondents in our study. Comprehensive recommendations for vaccination administration are only 285 
available on the datasheet. Vaccination recommendations change and it would therefore be prudent 286 
to check the datasheet before a vaccination session. As 95% of farmers would prefer their 287 
information on vaccination to come from their veterinarian (Cresswell and others 2014), he/she has 288 
an important knowledge transfer role when prescribing and advising on the use of vaccines in order 289 
to increase awareness and minimise the risks of ISL formation. The effect size of the different 290 
aspects of non-compliance however are unknown; i.e. whether ISLs are more prone to forming when 291 
injecting using a different route or site from the SPC, or whether inappropriate storage or needle 292 
hygiene have a greater impact. More research identifying the relative importance of each of these 293 
factors will help prioritize areas of focus when engaging with vets and farmers (Cresswell et al., 294 
2013). In addition, for this area of knowledge exchange, there is an opportunity for abattoir findings 295 
to be fed back to producers; currently the cost of ISLs is often carried by the abattoir and only in 296 
certain cases the farmer is contacted about observed ISLs. To create a feedback loop to the producer 297 
will highlight the importance of correct injection techniques to them. 298 
A reduction in ISLs was achieved by the beef industry in the USA through the publication of the 299 
National Cattlemen’s Beef Association’s guidelines. In Australia, the introduction of the Meat 300 
Standards Australia grading model to predict consumer scores on meat quality has provided an 301 
incentive for producers to improve beef quality (Polkinghorne and others 2008). In the UK the dairy 302 
levy board has recently produced guidelines for farmers regarding correct vaccination techniques 303 
(AHDB, 2014). However, farmers require individualised approaches when communicating disease 304 
prevention programmes (Jansen and others, 2010) and value vaccination advice from their own 305 
veterinarian (Cresswell and others 2014). Individual, tailored advice as well as the dissemination of 306 
advice from national initiatives is therefore required when aiming to optimise the use of injectable 307 
VMPs. This could be provided through theoretical and practical education (e.g. practice newsletters, 308 
on-farm advice) and in collaboration with abattoir staff who can provide feedback for the 309 
veterinarian and producer on carcase quality and ISL type and location.  310 
As alternatives, non-injectable vaccines, such as oral and intranasal vaccines, can be considered 311 
where available. However, non-injectable vaccines are more labour-intensive to apply in cattle, 312 
which may be prohibitive in an industry where ‘time’ is quoted as one of the main barriers to 313 
implementing herd health measures (Hall and Wapenaar 2012). 314 
This study was partly based on data collected via questionnaires which may have introduced a 315 
response bias by attracting responses only from those who have a particular interest in the subject 316 
matter (Dohoo and others 2003). In addition, recall bias may have occurred where inaccurate 317 
responses could have been provided which do not reflect true vaccination practices occurring on 318 
farm. If respondents have an interest in the topic they are likely to be more aware of the risks and 319 
are therefore expected to vaccinate correctly. This response bias may have resulted in an 320 
overestimation of the reported compliance on UK beef farms. Recall bias may have occurred, and is 321 
also more likely to underrepresent occurrence of poor vaccination compliance, as respondents 322 
would tend to give the expected answer instead of their true vaccination technique. The 323 
convenience sample used for the abattoir data and the practical difficulties encountered in collecting 324 
complete lesion data in the abattoirs may have influenced the results; however, in the absence of 325 
other published information this study provides an indication of ISL prevalence in beef carcases in 326 
the UK.  327 
Conclusion  328 
This study reports a 4.1% prevalence of ISLs in 2853 carcasses. ISLs have the potential to cause 329 
economic loss due to trimming and reduced carcase value and compromise animal welfare and meat 330 
quality. Deficits in compliance with recommended injection protocols may be contributing to the 331 
occurrence of ISLs. The role of vaccination in the occurrence of ISLs appears limited and is unlikely to 332 
be the predominant cause of ISLs. These findings pave the way for prospective longitudinal studies 333 
to further investigate the types and causes of ISLs in cattle. Feedback from the abattoir in 334 
conjunction with education on compliance with current datasheet recommendations on site of 335 
administration and appropriate needle usage from the prescribing veterinarian could have a key role 336 
in reducing ISL prevalence. 337 
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Table 1: Size of injection site lesions found in the rump and neck (n=72). The site of lesions found 474 
elsewhere on the carcasses (n=9) are not specified in this table. 475 
 476 
 477 
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 495 
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 501 
 502 
Size 
Total number of lesions 
found on carcasses (n=81) Rump (n=37) Neck (n=35) 
Small – 0.1-7.9 cm  22 10 10 
Medium – 8-15.9 cm  53 22 24 
Large – 16-23 cm 6 5 1 
Table 2: Frequency of each of the answers to the question 'When administering this vaccine by 503 
injection (using e.g. a syringe, vaccinator gun), which of the following apply on your farm? (Please 504 
tick all that apply)' (n=69). 505 
Answer Responses (n) 
A new needle is used to start the vaccination session 43% (30) 
Needle is changed when broken/blunt 43% (30) 
A different needle is used for injecting animals and 
drawing up vaccine from the bottle 
41% (28) 
A new needle is used between each different group of 
animals 
27% (19) 
A new needle is used between each vaccine bottle 26% (18) 
Other (please specify)* 9% (6) 
A new needle is used for each animal 6% (4) 
* ‘After 5 or 6 animals’, ‘approx every 10 cattle’, ‘a new needle is used after every 5 animals’, ‘new 506 
injecting needle every 3 or 4 animals’, ‘1 needle for large groups from same source with same 507 
vaccine, but needle disposed of after each batch’ and ‘I only have around 10 animals, so one group 508 
and needle doesn’t get blunt’. 509 
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 541 
Table 3: Frequency of each of the answers to the question 'What instructions did you follow when 542 
administering this vaccine? (Please tick all that apply)' (n=72). 543 
Answer Responses (n) 
I followed the instructions on the vaccine box/bottle 56% (40) 
I followed the instructions on the enclosed datasheet 40% (29) 
I did what I have done previously and did not need 
instructions 
20% (21) 
I followed the verbal instructions given by my vaccine 
supplier 
14% (10) 
I followed the instructions on the dispensing label 6% (4) 
I followed the written instructions given by my 
vaccine supplier 
6% (4) 
Other (please specify)* 1% (1) 
* ‘Administered by vet’ 544 
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 581 
Figure 1. Diagram on which respondents were asked to indicate with an ‘x’ where they would 582 
vaccinate their cattle. Subsequently the diagram was split into six sections. 583 
 584 
